decisionhealth Newsletters, Part B News - 2023 Issue 6 (June)
Capture correct level of risk for Rx management, parenteral controlled substances
Subscribe or sign in to view the full article.
Article Overview
This article discusses E/M documentation and medical decision-making risk for scenarios involving prescription drug management and parenteral controlled substances. It is aimed at coders, physicians, and qualified health care professionals who want to better understand how general risk categories are applied in different inpatient and post-procedure situations. The article summarizes guidance shared during an AMA/CPT webinar and focuses on broad documentation concepts, scenario-based discussion, and how clinicians should think about ongoing assessment in the medical record.
Why This Topic Matters
Accurate risk assignment affects E/M level selection and documentation integrity. The article helps readers understand how common medication-related scenarios are evaluated without relying on assumptions that can lead to overcoding or undercoding.
Article Sections
-
Coding
Introductory context for the topic and why the medication-related risk category in E/M medical decision-making is being discussed.
-
Inpatient Rx drug management
A scenario-based discussion of prescription drug management in an inpatient setting, including how risk is considered across multiple hospital days.
-
Parenteral controlled substances – high risk
A postoperative inpatient scenario that addresses risk considerations associated with parenteral controlled substances in a high-acuity context.
-
Parenteral controlled substances – moderate risk
A post-procedure scenario that compares the general level of risk associated with parenteral controlled substances in a lower-acuity context.
-
Resource
Source reference for the webinar and related AMA event material mentioned in the article.
What You Will Learn
- How the article frames risk in E/M medical decision-making for medication-related scenarios
- How prescription drug management is discussed in inpatient documentation
- How parenteral controlled substances are considered in different clinical contexts
- How scenario-based guidance from an AMA/CPT webinar is presented for coding education
Who Should Read This
- Medical coders
- Physicians
- Qualified health care professionals
- E/M documentation staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com